Influence & Innovation: Shaping What Comes Next in Biotech and Pharma

Hosted alongside the American Society of Clinical Oncology (ASCO) Annual Meeting, this gathering convenes senior women leaders across biotech, pharma, healthcare, and investing to explore the forces reshaping the biopharma landscape.

Amid shifting capital markets, rapid scientific advancement, and increasing pressure on funding, partnerships, and exits, biotech / pharma is entering a defining moment. The conversation is no longer just about what gets built, but who shapes what comes next and how decisions across the ecosystem influence outcomes.

Bringing together operators, investors, LPs, and corporate leaders, this discussion will explore:

• The current and forward-looking state of the global biotech  market

• Where innovation is accelerating and where it is constrained

• How capital, partnerships, and scale are evolving across the ecosystem

• What this moment requires from leaders across biotech, pharma, and healthcare

  
  

Attendees will leave with a sharper understanding of the market, a stronger cross-sector network, and a clearer sense of how to engage whether through building, investing, advising, or partnering.